Treatment of mammalian reaction of IgE interactions

Details Treatment of mammalian reaction of IgE interactions Treatment of mammalian reaction of IgE interactions

2011-02-01

2011-02-01

Swartz, Rodney P. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S009100, C424S009200, C424S130100, C424S139100, C424S171100, C424S184100, C424S234100, C424S236100, C424S247100, C424S278100

Reexamination Certificate

active

07879340

ABSTRACT:
A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.

REFERENCES:
patent: 5670484 (1997-09-01), Binder
patent: 6429189 (2002-08-01), Borodic
patent: 6822076 (2004-11-01), Bigalke
patent: 7537773 (2009-05-01), Borodic
patent: 7608275 (2009-10-01), Deem
patent: 7655243 (2010-02-01), Deem
patent: 2002/0082197 (2002-06-01), Aoki
patent: 2003/0157134 (2003-08-01), Aoki
patent: 2004/0247606 (2004-12-01), Borodic
patent: 95/28171 (1995-10-01), None
patent: 9528171 (1995-10-01), None
patent: WO95/28171 (1995-10-01), None
patent: 0015245 (2000-03-01), None
patent: 0200172 (2002-01-01), None
Shaari et al (Otolaryngology-Head and neck Surgery, 112:4, Apr. 1995).
Shaari, C.M., et al. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngology—Head and Neck Surgery, vol. 112, pp. 566-571, 1995.
Rohrbach s, et al, Medline, NLM 11713429, Nov. 2001 “Minimally invasive application of Botulinum toxin type A in nasal hypersecretion”.
Ural Murat et al , Medline NLM 14710908 Dec. 2003 “Effect of botulinum Toxin type A on nasal symptoms in patients with allergic Rhititis: etc”.
Hoffman, Hans Jürgen, et al., “SNARE Proteins Are Critical for Regulated Exocytosis of ECP from Human Eosinophils,” Biochemical and Biophysical Research Communications, vol. 282, (2001), p. 194-199.
Mazzone, Stuart B., et al., “Evidence for Differential Reflex Regulation of Cholinergic and Noncholinergic Parasympathetic Nerves Innervating the Airways,” American Journal of Respiratory and Critical Care Medicine, vol. 165, (2002), p. 1076-1083.
Logan, M.R., et al., “A Critical Role for Vesicle-Associated Membrane Protein-7 in Exocytosis from Human Eosinophils and Neutrophils,” Allergy, vol. 61, (2006), p. 777-784.
Rohrbach, Saskia, et al., “Botulinum Toxin Type A Induces Apoptosis in Nasal Glands of Guinea Pigs,” Annals of Otology, Rhinology and Laryngology, vol. 101, (2001), p. 1045-1050.
Ünal, Murat, et al., “Effect of Botulinum Toxin Type A on Nasal Symptoms in Patients with Allergic Rhinitis: A Double-Blind, Placebo-Controlled Clinical Trial,” Acta Otolaryngol,vol. 123, (2003), p. 1060-1063.
Shaari, Christopher M., et al., “Rhinorrhea is Decreased in Dogs After Nasal Application of Botulinum Toxin,” Otolaryngology—Head and Neck Surgery, vol. 112, No. 4, (1995), p. 566-571.

Affiliated with

Also associated with

Rating

Treatment of mammalian reaction of IgE interactions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of mammalian reaction of IgE interactions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mammalian reaction of IgE interactions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2632837